Entero Therapeutics: Funding, Investors & Team (Oct 2026)
Entero Therapeutics is a biopharmaceutical company in the late stages of clinical development that focuses on creating specific therapies for digestive system disorders. The company's efforts are aimed at addressing important gaps in gastrointestinal health, such as the development of latiglutenase for celiac disease, capeserod for conditions like gastroparesis, and adrulipase for aiding digestion in patients with cystic fibrosis and chronic pancreatitis.
Entero Therapeutics has raised $5.0M across 2 funding rounds on record, the most recent an undisclosed round of $3.0M announced in Aug 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Entero Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Entero Therapeutics Funding Rounds
Entero Therapeutics raised $2.0M in an undisclosed round announced in Feb 2025.
6 months later, an undisclosed round of $3.0M was announced in Aug 2025.
Entero Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Entero Therapeutics Funding Compared to Other Biotechnology Startups
Entero Therapeutics' latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Entero Therapeutics in Biotechnology and Boca Raton
Companies Similar to Entero Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Entero Therapeutics Funding FAQs
What does Entero Therapeutics do?
Entero Therapeutics is a biopharmaceutical company in the late stages of clinical development that focuses on creating specific therapies for digestive system disorders. The company's efforts are aimed at addressing important gaps in gastrointestinal health, such as the development of latiglutenase for celiac disease, capeserod for conditions like gastroparesis, and adrulipase for aiding digestion in patients with cystic fibrosis and chronic pancreatitis.
How much funding has Entero Therapeutics raised?
Entero Therapeutics has raised $5.0M across 2 rounds on record. The most recent is an undisclosed round of $3.0M announced in Aug 2025.
When did Entero Therapeutics last raise funding?
Entero Therapeutics' most recent funding round on record is an undisclosed round of $3.0M, announced in Aug 2025.
Who founded Entero Therapeutics?
FundedIQ lists Daniel Dupret (Founder) at Entero Therapeutics.
Where is Entero Therapeutics headquartered?
Entero Therapeutics is based in Boca Raton, Florida, United States.
How many employees does Entero Therapeutics have?
Entero Therapeutics is in the 11-50 employee band.
How does Entero Therapeutics' funding compare to other Biotechnology startups?
Entero Therapeutics' latest round of $3.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Entero Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Entero Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.